Published in Exp Dermatol on August 01, 1996
Immunotherapy for advanced renal cell cancer. Cochrane Database Syst Rev (2005) 3.88
Emergency ultrasound-based algorithms for diagnosing blunt abdominal trauma. Cochrane Database Syst Rev (2005) 2.28
Soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malaria. J Infect Dis (1992) 1.98
Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer (1997) 1.85
Treatment decisions in palliative cancer care: patients' preferences for involvement and doctors' knowledge about it. Eur J Cancer (1997) 1.83
Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol (2000) 1.82
The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Am Acad Dermatol (1999) 1.65
Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology. Br J Dermatol (2015) 1.55
Systematic review and meta-analysis of antibiotic therapy for bone and joint infections. Lancet Infect Dis (2001) 1.53
[Evidence-based medicine and anaesthesiology--six steps towards implementation into clinical practice]. Anasthesiol Intensivmed Notfallmed Schmerzther (2003) 1.37
Targeted therapy for advanced renal cell carcinoma. Cochrane Database Syst Rev (2008) 1.35
A likelihood ratio approach to meta-analysis of diagnostic studies. J Med Screen (2003) 1.30
Systematic review and meta-analysis of emergency ultrasonography for blunt abdominal trauma. Br J Surg (2001) 1.20
[Emergency ultrasound for blunt abdominal trauma--meta-analysis update 2003]. Zentralbl Chir (2003) 1.15
Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia. Blood (1989) 1.14
IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity. J Am Acad Dermatol (2000) 1.11
The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases. Am J Pathol (2000) 1.10
Practical aspects of quality-of-life measurement: design and feasibility study of the quality-of-life recorder and the standardized measurement of quality of life in an outpatient clinic. Cancer Treat Rev (1996) 1.05
Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes. J Invest Dermatol (2000) 1.04
Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidence. J Am Acad Dermatol (1999) 1.03
NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage. J Pathol (2007) 1.01
Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol (1995) 1.00
Immunotherapy for advanced renal cell cancer. Cochrane Database Syst Rev (2000) 0.96
Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid. Arch Dermatol Res (1996) 0.94
The IL-8 release from cultured human keratinocytes, mediated by antibodies to bullous pemphigoid autoantigen 180, is inhibited by dapsone. Clin Exp Immunol (2001) 0.93
High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and type B chronic lymphocytic leukemia. J Clin Invest (1992) 0.93
Human interleukin-7 induces proliferation of neoplastic cells from chronic lymphocytic leukemia and acute leukemias. Blood (1991) 0.92
Scalp necrosis in temporal (giant cell) arteritis:implications for the dermatologic surgeon. Clin Exp Dermatol (1996) 0.92
Autoimmune and inherited subepidermal blistering diseases: advances in the clinic and the laboratory. Adv Dermatol (2000) 0.92
Rituximab in refractory autoimmune bullous diseases. Clin Exp Dermatol (2006) 0.92
Rapid response of IgA pemphigus of subcorneal pustular dermatosis type to treatment with isotretinoin. J Am Acad Dermatol (2000) 0.90
Polymorphism within the second intron of the IL-1 receptor antagonist gene in patients with hematopoietic malignancies. Cytokines Mol Ther (1996) 0.90
Mapping of epitopes on the BP180 ectodomain targeted by IgA and IgG autoantibodies in patients with the lamina lucida-type of linear IgA disease. Arch Dermatol Res (2001) 0.88
[Reversible germ cell toxicity following aggressive chemotherapy in patients with testicular tumors: results of a prospective study]. Klin Wochenschr (1989) 0.88
Elevated levels of interleukin-8 in blister fluid of bullous pemphigoid compared with suction blisters of healthy control subjects. J Am Acad Dermatol (1996) 0.87
Generalized cowpox infection in a patient with Darier disease. Br J Dermatol (2011) 0.87
Interleukin-6 stimulates the hypothalamus-pituitary-adrenocortical axis in man. J Clin Endocrinol Metab (1994) 0.87
Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180. J Autoimmun (2000) 0.86
Polymorphism of the tumour necrosis factor-alpha and lymphotoxin-alpha genes in chronic lymphocytic leukaemia. Br J Haematol (1997) 0.86
Pemphigoid nodularis associated with autoantibodies to the NC16A domain of BP180 and a hyperproliferative integrin profile. J Am Acad Dermatol (2001) 0.85
Rapid response of treatment-resistant pemphigus foliaceus to the anti-CD20 antibody rituximab. Br J Dermatol (2003) 0.85
Stimulation of human NK-cell activity by cultured cells. I. Response of normals. Int J Cancer (1978) 0.85
IgE autoantibodies against the intracellular domain of BP180. Br J Dermatol (2008) 0.85
A successful treatment with ustekinumab in a case of antilaminin-γ1 pemphigoid associated with psoriasis. Br J Dermatol (2013) 0.85
Spontaneous interferon-alpha antibodies in a patient with pure red cell aplasia and recurrent cutaneous carcinomas. Ann Hematol (1991) 0.85
Subacute cutaneous lupus erythematosus associated with terbinafine. Clin Exp Dermatol (2009) 0.85
Cicatricial pemphigoid with circulating autoantibodies to beta4 integrin, bullous pemphigoid 180 and bullous pemphigoid 230. Br J Dermatol (2001) 0.84
[New aspects on the pathogenesis of bullous pemphigoid]. Hautarzt (2000) 0.84
Binding of avian IgY to type VII collagen does not activate complement and leucocytes and fails to induce subepidermal blistering in mice. Br J Dermatol (2008) 0.84
[Challenge of evidence-based medicine: sense and non-sense of diagnostic tests in gynecology]. Zentralbl Gynakol (2001) 0.84
Clearance rates of circulating and tissue-bound autoantibodies to type VII collagen in experimental epidermolysis bullosa acquisita. Br J Dermatol (2010) 0.83
IgG, IgA and IgE autoantibodies against the ectodomain of desmoglein 3 in active pemphigus vulgaris. Br J Dermatol (2001) 0.83
Tufted hair folliculitis associated with pemphigus vulgaris. J Eur Acad Dermatol Venereol (2003) 0.83
Treatment-induced antibodies to interleukin-2. Biotherapy (1997) 0.83
[Chronic bullous disease of childhood. Long-term therapy over 8 years with 4,4'-diaminodiphenylsulfone]. Hautarzt (2012) 0.83
Autocrine and paracrine regulation of neoplastic cell growth in hairy cell leukemia. Leuk Lymphoma (1995) 0.83
Evidence for the involvement of host-derived OKT8-positive T cells in the rejection of T-depleted, HLA-identical bone marrow grafts. Transplantation (1987) 0.83
In vivo confocal laser scanning microscopy for non-invasive diagnosis of pemphigus foliaceus. Skin Res Technol (2009) 0.82
Elevated expression and release of tissue-type, but not urokinase-type, plasminogen activator after binding of autoantibodies to bullous pemphigoid antigen 180 in cultured human keratinocytes. Clin Exp Immunol (2004) 0.82
[Detection of tumorantigens of hypernephroma (author's transl)]. Urol Int (1973) 0.82
[Methods of health economic evaluation for health services research]. Gesundheitswesen (2010) 0.81
Pemphigoid gestationis: maternal sera recognize epitopes restricted to the N-terminal portion of the extracellular domain of BP180 not present on its shed ectodomain. Br J Dermatol (2003) 0.81
p53 mutations in hairy cell leukemia. Leukemia (2000) 0.81
Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180. Br J Dermatol (2001) 0.81
Natural killer cell activity in preleukaemia. Lancet (1982) 0.81
Comparison of German language versions of the QWB-SA and SF-36 evaluating outcomes for patients with prostate disease. Qual Life Res (2001) 0.81
Interferon-alpha antibodies in autoimmune diseases. J Interferon Res (1989) 0.81
[Spontaneous remission of sudden deafness]. HNO (2000) 0.81
Epidermolysis bullosa acquisita with ultraviolet radiationsensitivity. Br J Dermatol (2000) 0.81
The electrophoretic mobility test (EMT) and cancer diagnosis. Z Immunitatsforsch Immunobiol (1978) 0.80
Successful adjuvant treatment of severe bullous pemphigoid by tryptophan immunoadsorption. Clin Exp Dermatol (2005) 0.80
[Successful treatment of subcorneal pustular type of IgA pemphigus]. Hautarzt (2005) 0.80
Impaired natural killer cell function in hemophiliacs with or without continuous substitution. Blut (1984) 0.80
Differential effect of GM-CSF and G-CSF in cyclic neutropenia. Lancet (1990) 0.80
[Treatment of lichen planus pemphigoides with acitretin and pulsed corticosteroids]. Hautarzt (2003) 0.80
A randomized, investigator-blinded efficacy assessment study of stand-alone emollient use in mild to moderately severe atopic dermatitis flares. J Eur Acad Dermatol Venereol (2014) 0.80
[Immune phenotyping of mononuclear infiltrate in bullous pemphigoid]. Hautarzt (1992) 0.80
Serum levels of anti-type VII collagen antibodies detected by enzyme-linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions. J Eur Acad Dermatol Venereol (2012) 0.80
Protein A immunoadsorption: a novel and effective adjuvant treatment of severe pemphigus. Br J Dermatol (2003) 0.79
Antibodies to interferon-alpha: a novel type of autoantibody occurring after allogeneic bone marrow transplantation. Bone Marrow Transplant (1996) 0.79
A double-blind, randomized, vehicle-controlled efficacy assessment study of a skin care formulation for improvement of mild to moderately severe acne. J Eur Acad Dermatol Venereol (2013) 0.79
Anti-interferon-gamma antibodies in a patient undergoing interferon-gamma treatment for systemic mastocytosis. J Interferon Cytokine Res (1996) 0.79
Subepidermal blistering disease with autoantibodies against a novel dermal 200-kDa antigen. J Dermatol Sci (2000) 0.79
Pemphigus. S2 Guideline for diagnosis and treatment--guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol (2014) 0.79
Development of a simple enzyme-linked immunosorbent assay for the detection of autoantibodies in anti-p200 pemphigoid. Br J Dermatol (2010) 0.79
Increased incidence of pemphigus vulgaris in southern Europeans living in Germany compared with native Germans. J Eur Acad Dermatol Venereol (2002) 0.79
[Pemphigoid gestationis without blisters]. Hautarzt (2000) 0.79
Childhood epidermolysis bullosa acquisita: a novel variant with reactivity to all three structural domains of type VII collagen. Br J Dermatol (2002) 0.79
High-titre interferon-alpha antibodies in a patient with chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant (1994) 0.78
A child with localized vulval pemphigoid and IgG autoantibodies targeting the C-terminus of collagen XVII/BP180. Br J Dermatol (1999) 0.78
Epitope mapping of BP230 leading to a novel enzyme-linked immunosorbent assay for autoantibodies in bullous pemphigoid. Br J Dermatol (2012) 0.78
CD19+ B lymphocytes are the major source of human antibody-secreting hybridomas generated by electrofusion. J Immunol Methods (2001) 0.78
Bone densitometry and histomorphometry in patients with hairy cell leukemia. Leuk Lymphoma (1994) 0.78
Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins. Br J Dermatol (2007) 0.78
Impaired T-cell and NK-cell function in patients with preleukemia. Blut (1982) 0.78
Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients. Br J Dermatol (2011) 0.78
[Lay assessment of health care services using therapy for rectal cancer as an example]. Zentralbl Chir (2008) 0.78
Antiepiligrin cicatricial pemphigoid: an underdiagnosed entity within the spectrum of scarring autoimmune subepidermal bullous diseases? Arch Dermatol (1999) 0.78
IgG1 and IgG3 are the major immunoglobulin subclasses targeting epitopes within the NC16A domain of BP180 in pemphigoid gestationis. J Invest Dermatol (1999) 0.78